Results 31 to 40 of about 1,090 (156)

Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves’ Orbitopathy: A Pilot Study

Frontiers in Endocrinology, 2022
BackgroundTherapy with intravenous glucocorticoids (GCs) is associated with various side effects, however, the impact on bone remains elusive. Trabecular bone score (TBS) is a diagnostic tool providing information on bone microarchitecture based on ...
Joanna Rymuza, Katarzyna Pelewicz, Jerzy Przedlacki, Piotr Miśkiewicz   +3 more
doaj   +1 more source

The Outcomes of Balanced Orbital Decompression for Dysthyroid Optic Neuropathy: Focusing on Choroiretinal Folds with and without Optic Disc Edema

Disease Markers, Volume 2023, Issue 1, 2023., 2023
Purpose. To assess the outcomes of balanced orbital decompression for chorioretinal folds (CRFs) with and without optic disc edema (ODE) in dysthyroid optic neuropathy (DON). Method. A retrospective, interventional study was performed at Sun Yat‐sen Memorial Hospital from April 2018 to November 2021.
Peng Zeng, Xiao-wen Deng, Peng Tian, Yuan-yu Peng, Ming-tong Xu, Shi-you Zhou, Mei Wang, Gaetano Isola   +7 more
wiley   +1 more source

Quality of life in Graves' orbitopathy [PDF]

Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2011
The quality of life of patients with Graves' orbitopathy (GO) may be seriously damaged due to the changes in appearance, working abilities and everyday activities. The reasons for the deterioration in quality of life in GO are proptosis, diplopiae and/or
Ćirić Jasmina
doaj   +1 more source

Current concepts regarding Graves’ orbitopathy

Journal of Internal Medicine, Volume 292, Issue 5, Page 692-716, November 2022., 2022
Abstract Graves’ orbitopathy (GO) is an orbital autoimmune disorder and the main extrathyroidal manifestation of Graves’ disease, the most common cause of hyperthyroidism. GO affects about 30% of Graves’ patients, although fewer than 10% have severe forms requiring immunosuppressive treatments.
Luigi Bartalena, Maria Laura Tanda
wiley   +1 more source

Thyroid disease‐specific quality of life questionnaires ‐ A systematic review

Endocrinology, Diabetes &Metabolism, Volume 5, Issue 5, September 2022., 2022
The aim of this systematic review was to provide an overview of currently available thyroid‐specific Qol questionnaires with focus on the quality of the validation studies and on the clinical applicability of the questionnaires and the identification of gaps regarding specific research needs.
Verena Uslar, Caroline Becker, Dirk Weyhe, Navid Tabriz   +3 more
wiley   +1 more source

Assessment of risk of obstructive sleep apnea with thyroid eye disease and its activity

Indian Journal of Ophthalmology, 2023
Purpose: To evaluate the association between obstructive sleep apnea (OSA) and thyroid eye disease (TED) and its effect on disease activity. Methods: A prospective case–control study was conducted from January 2020 to March 2022.
Namita Kumari, Nitish Arora, Sima Das, Sweety Tiple, Harshdeep Singh, Narendra Patidar, Mihir Mishra, Atanu Majumdar   +7 more
doaj   +1 more source

Repurposing picropodophyllin as a potential thyroid eye disease treatment via delaying mitotic clonal expansion through a patient‐derived preclinical platform

, 2023
Clinical and Translational Medicine, Volume 13, Issue 4, April 2023.
Jing Hu, Jiali Wu, Qihuang Jin, Ling Zhang, Ning Shen, Yiyang Shu, Lu Cheng, Jian Zhang, Guangyi Hu, Kangjia Lv, Qizhi Jian, Hui Chen, Fang Zhang, Xiaodong Sun   +13 more
wiley   +1 more source

Evaluasi 97 Pasien Oftalmopati Graves’ Selama 3 Tahun Menggunakan Algoritma Eugogo dan Konsensus Nasional

Ophthalmologica Indonesiana, 2021
Introduction and Objective: Graves’ ophthalmopathy (GO) is an autoimmune disorder of the orbit that is closely associated with Graves’ diseases. Various classification system was proposed to evaluate clinical findings in GO. As controversy exists in assessment and management of GO there is a need to evaluate and improve diagnostic criteria using ...
Claudia Hartomuljono, Syntia Nusanti
openaire   +2 more sources

PREGO (presentation of Graves\u27 orbitopathy) study: changes in referral patterns to European Group On Graves\u27 Orbitopathy (EUGOGO) centres over the period from 2000 to 2012

Background/aims The epidemiology of Graves\u27 orbitopathy (GO) may be changing. The aim of the study was to identify trends in presentation of GO to tertiary centres and initial management over time.Methods Prospective observational study of European ...
Okosieme O, Bernard M, Toruner FB, Mathiopoulou L, Azzolini C, Dayan C, Salvi M, Konuk O, Clarke L, Neoh C, Nardi M, Kahaly GJ, Daumerie C, Pitz S, Dickinson J, Lane C, Orgiazzi J, Covelli D, Hegedus L, Menconi F, von Arx G, Boschi A, Marcocci C, Morris D, Perros P, Ciric S, Wiersinga W, Lazarus J, Moller L, Ayvaz G, Bournaud C, Eckstein A, Fichter N, Marino M, Bartalena L, Vardanian-Vartin C, Curro N, Lareida J, Fuhrer D, Zarkovic M, Knezevic M, Pearce S, Brix TH, Leo M, Baldeschi L   +44 more
core   +4 more sources

Evaluation of the Graves’ Orbitopathy-Specific Quality of Life Questionnaire in the Mainland Chinese Population

Journal of Ophthalmology, 2019
Purpose. To study the clinical significance of the Graves’ orbitopathy-specific quality of life (GO-QOL) questionnaire in mainland Chinese patients. Methods.
Peng Zeng, Shu-xian Fan, Zi-jing Li, Yuan-yu Peng, Yu-xin Hu, Ming-tong Xu, Mei Wang   +6 more
doaj   +1 more source